scispace - formally typeset
M

Min Yang

Researcher at Sun Yat-sen University

Publications -  8
Citations -  130

Min Yang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Population & Percutaneous coronary intervention. The author has an hindex of 6, co-authored 8 publications receiving 86 citations.

Papers
More filters
Journal ArticleDOI

Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation

TL;DR: The Kaplan-Meier cumulative MACE-free survival curves with a log-rank test showed that the presence of high ratio of LDL-C/HDL-C was associated with higher incidences of MACE after PCI with DES implantation, associated with cardiovascular events in patients with ACS after PCI.
Journal ArticleDOI

Analysis of CYP2C19 Genetic Polymorphism in a Large Ethnic Hakka Population in Southern China.

TL;DR: This study is the first to report on CYP2C19 polymorphisms in the Hakka population, and may help to optimize pharmacotherapy effectiveness by providing personalized medicine to this ethnic group in the near future.
Journal ArticleDOI

Serum lipid profiles in patients with acute myocardial infarction in Hakka population in southern China.

TL;DR: Levels of TC, LDL, HDL, and TG were higher in females than males for the elderly Hakka population in southern China, confirming that serum lipid levels varied in age and gender in Hakka patients with acute myocardial infarction.
Journal ArticleDOI

Genetic Polymorphisms of the Mitochondrial Aldehyde Dehydrogenase ALDH2 Gene in a Large Ethnic Hakka Population in Southern China.

TL;DR: The findings of this study have provided new information on the ALDH2 gene polymorphisms in the Hakka ethnic population residing in the Meizhou area of Guangdong Province, China, including an understanding of the origin of the atypical AL DH2*2 allele.
Journal ArticleDOI

Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China

TL;DR: There was no significant association between the carrier status and the clinical outcome at 1, 6, and 12 months of genotype-guided antiplatelet therapy, and new light is shed on the important benefit of testing CYP2C19 polymorphisms before prescribing clopidogrel in patients treated with drug-eluting stent implantation after PCI.